S0353, Gemcitabine in Treating Patients With Recurrent Bladder Cancer That Has Not Responded to Previous Bacillus Calmette-Guerin
NCT00234039
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
58
Enrollment
NETWORK
Sponsor class
Conditions
Bladder Cancer
Interventions
DRUG:
gemcitabine hydrochloride
Sponsor
SWOG Cancer Research Network
Collaborators
[object Object]